The constitutive fragile site at chromosomal band 3p14.2, FRA3B, is the most active common fragile site in the human genome. We have localized aphidicolininduced breakpoints to two distinct clusters, separated by 200 Kb, in FRA3B (Paradee et al., 1996). Sequence analysis of these regions identi®ed two polymorphic microsatellite markers immediately adjacent to each of these breakpoint clusters. In this report we have used these two new microsatellites and 14 additional 3p microsatellites to analyse chromosome 3p breakage and loss in 94 sporadic RCC samples, including nonpapillary, papillary and oncocytomas. We have found heterozygous loss of 3p14 sequences in 460% of the RCC samples, including both clear cell and papillary renal cell carcinomas. We have found frequent breakage in the region immediately surrounding FRA3B, demonstrating that FRA3B does play a role in chromosome breakage and loss in RCC. In contrast to other reports, 450% of the papillary tumors also showed LOH of 3p markers. We also observed microsatellite instability (MIN) with most of the tested markers in seven of eight oncocytomas and one of 69 clear cell carcinomas. The MIN in some oncocytomas was of the RER+ (replication error) type I phenotype. None of the ®ve 3p14.2 markers detected any homozygous deletions in tumor samples, but 69/94 (73%) of the tumors had LOH for the region, which includes the recently identi®ed FHIT gene.
Introduction
Renal cell carcinoma (RCC), is the most frequent tumor of the kidney. According to the classi®cation by Thoenes et al. (1986) and StoÈ rkel et al. (1995) clear cell RCC and chromophilic RCC originate from the proximal tube, and chromophobe RCC and renal oncocytomas originate from the collecting duct. While clear cell and chromophilic tumors have the highest potential to metastasize, oncocytomas are usually considered benign. Schwerdtle et al. (1996) have demonstrated that in the chromophobe RCCs which have a better prognosis, chromosomal regions other than 3p are involved. Renal tumors are also classi®ed histologically as papillary or nonpapillary based on their growth patterns. These are divided further according to cell type (clear cell, granular cell, mixed clear and granular cell) (Bagley et al., 1990) .
Several reports have implicated loss of sequences on the short arm of chromosome 3 as one of the leading events in the development of clear cell RCCs. The regions of allelic losses have been mapped to three distinct regions of this chromosome (Yamakawa et al., 1991; Kovacs et al., 1988) . However, several investigators have also suggested that 3p deletions were not present in papillary RCC and are con®ned only to nonpapillary RCCs (Zbar et al., 1987; Morita et al., 1991; Kovacs et al., 1989) . The benign oncocytomas also do not reveal deletion of 3p sequences (Presti et al., 1993) but exhibit microsatellite instabilities (Thrash-Bingham et al., 1995) . The most common microsatellite instability (MIN) associated with oncocytomas is a two to four base pair insertion in a CA repeat (Thrash-Bingham et al., 1995) . Druck et al. (1995) found that 31/35 clear cell RCCs showed a common region of loss between D3S1312 and D3S1481, which¯ank the hRCC (hereditary renal cell carcinoma) translocation breakpoint. Ohta et al. (1996) recently reported the identi®cation of the FHIT gene, which spans both the hRCC breakpoint and FRA3B. The FHIT gene consists of 10 exons and codes for a 1.1 Kb transcript. The ®rst three exons of the FHIT gene are located proximal to the t(3;8) breakpoint and the remaining seven exons lie distal to it . The ®rst coding exon, exon 5, lies within the FRA3B region, distal to the marker D3S2757 and proximal to D3S1300. The noncoding exon 4 of the FHIT gene is distal to the marker D3S1481 (Figure 1 ). Aberrant transcripts of this gene were detected in several dierent digestive tract cancers (50%) , lung tumors both SCLC (80%) and NSCLC (40%) (Sozzi et al., 1996a) , in 57% of Merkel cell carcinoma (Sozzi et al., 1996b) , in 20% of breast cancers , and more recently in 55% of squamous cell carcinoma of the head and neck (Virgilio et al., 1996) . Sequence analysis of the RT-PCR rescued transcripts of the FHIT gene revealed that in all cases complete exons were lost. Exon 5, which contains the translational start site, and exon 8, which contains the histidine triad domain, were targets for more frequent deletions . However, work by Thiagalingam et al. (1996) failed to ®nd any alterations in FHIT in any colorectal tumors, and they have suggested that the RT-PCR generated FHIT alterations observed by other workers might simply represent alternative splicing variants, or could simply re¯ect the plasticity of the cancer cell genome, especially within the FRA3B region. No mutations were observed in FHIT in RCCs and no homozygous deletions within the FHIT gene were seen in RCC samples (Ohta et al., 1996 and CHCM Buys, personal communication) , although allelic loss in the FRA3B/ t(3;8) breakpoint region has been observed in most clear cell RCCs examined (Druck et al., 1995) . The possible role of FHIT as a tumor suppressor gene in RCCs, or any other cancers, therefore remains to be demonstrated.
With the availability of closely spaced markers on the short arm of human chromosome 3, it is now possible to de®ne more precisely the chromosomal regions of allele loss and breakpoints in the tumors. This study has attempted to determine whether (1) all of 3p is lost in these tumors, (2) breakpoints in FRA3B are common events in RCC, and (3) whether 3p deletions are seen in all subtypes of RCCs including papillary and nonpapillary tumors. Figure 1 shows the location of the various microsatellite markers used in our analysis of 3p breakpoints in RCC and the region de®ned by the 3p14.2 YAC clone YC850A6. Table 1 summarizes the results of the LOH studies on the 94 RCC samples. Many of the tested microsatellite markers showed LOH in a signi®cant proportion of informative tumors. Second, many of the RCC samples had multiple 3p breakpoints. In any one sample, breakpoints are de®ned when there is retention of heterozygosity for one marker and LOH for an adjacent informative marker. Very few (8/94) tumors showed loss of whole chromosomal arms. The tumors that show whole chromosomal loss were R16, R24, R27, R30, R39, R42, RC10 and RC13. Two of these tumors R24, and R27, were papillary RCCs and the other six were nonpapillary clear cell RCCs.
Results

3p breakpoints analysis
The microsatellite markers provided information about microsatellite instability and LOH in the samples tested and also enabled us to pinpoint chromosome breakpoints on one of the chromosome 3 homologs. Each adjacent pair of microsatellite markers was scored for the number of times that both markers were informative with a tested sample and for the number of times that a breakpoint could be detected between the two informative markers. The number of samples with two¯anking informative markers ranged from 63 with the¯anking microsatellites D3S1599 and D3S1560 to 17 with the¯anking microsatellites D3S1480 and D3S4260. Each of the RCC samples was then scored for the total number of breakpoints. In several of the RCC samples multiple breakpoints were detected (Table 1) . In contrast to the results reported by Wilhelm et al., who generally detected only one breakpoint with distal loss, we saw frequent breakpoints in each sample. This clearly indicates that most of the samples had interstitial deletions of 3p sequences and not complete loss of one chromosome 3 homolog.
LOH analysis
The 16 3p microsatellite markers used to analyse the 94 RCC samples were informative in variable numbers of the RCC samples. The least informative markers were the two new microsatellite markers D3S4260 (informative in 50 samples) and D3S2757 (informative in 52 samples), and the most informative marker was D3S1481, (informative in 78 samples) (see Figure 1) . Figure 2 shows several representative microsatellite analyses of matched normal-tumor pairs. Figure 3 shows the results of microsatellite analysis with one tumor, RC25, which had seven detectable breakpoints with the markers analysed.
Each of the 16 microsatellites was scored for the number of times the marker detected LOH, divided by the number of informative samples for that microsatellite. The results of this analysis are shown in a graphical form in Figure 4 . This Figure illustrates that the loss of 3p sequences was a rather common event in RCC with LOH for the markers varying from 12% for D3S1599 to 64% for D3S1481. The region that showed the greatest LOH extended from the 3p14.1 marker D3S1600 to the distal FRA3B marker D3S1300. Moreover, microsatellites from the remainder of 3p also showed frequent LOH in these samples (Figure 4) . Markers D3S1606 at 3p21.1, D3S1029 at 3p21.3 and D3S1270 at 3p26 showed 42.5%, 34%, and 37% LOH respectively. This is consistent with the existence of three distinct regions of LOH in RCCs, one at 3p13-3p14.2, one in 3p21, and one in the telomeric region, 3p25-3p26. The majority of the samples analysed were clear cell RCC (69) and most of these detected LOH at one or more 3p microsatellites. However, we also analysed nine papillary RCC samples, ®ve oncocytomas and four oncocytotic RCCs. LOH was detected at one or more microsatellite markers in ®ve of nine papillary RCCs examined. Several of the oncoctyomas and oncocytotic RCC samples tested showed LOH of some of the markers (Table 1: samples RC35, 36, 37, 38, 46, and 63) . One of the oncocytomas that had no MIN (RC61) had LOH of two markers, one in 3p14.1 (D3S1312) and the other in 3p14.2 (D3S1481).
Microsatellite instability
Eight samples showed microsatellite instability at most of their loci including RC33, RC35, RC36, RC37, RC38, RC46, RC63 and R32. An additional nine samples showed MIN for just one, or a few tested markers: RC3, RC6, RC10, RC17, RC26, RC39, RC70, RC73 and R30. Of the eight samples that had MIN at most loci, seven were either oncocytomas or oncocytotic RCCs (see Table 2 ) and the one remaining sample, RC63, was a clear cell RCC. The nine samples with some MIN included eight clear cell RCCs and one granular/spindle RCC. The MIN in oncocytomas included both contractions and expansions of two to more than four basepairs. In most of the samples both the alleles showed MIN. For example, in tumor 33, with the marker D3S1270, one allele showed an expansion, and the other corresponding allele had contracted with respect to the normal alleles ( Figure 5 ). Also, in tumor 37 with microsatellite marker D3S1029, the insertion in this allele was more than four base pairs ( Figure 5 ).
Discussion
The loss of heterozygosity (LOH) data presented here are consistent with reports by other groups that loss of DNA from chromosome 3 is a characteristic and possibly an initial event in the development of renal cell carcinomas. Molecular and cytogenetic analysis with highly polymorphic microsatellite markers have delineated three distict regions of common allele loss in RCCs (Yamakawa et al., 1991; Kovacs et al., 1988) . A putative tumor suppressor gene, the VHL gene, has been cloned from chromosome 3p, at 3p25-26 (Latif et al., 1993) . Somatic mutations in the VHL allele has been demonstrated in 50 ± 60% of sporadic nonpapillary RCCs that have LOH in this region (Shuin et al., 1994) .
A second region, 3p14, was the focus of the present study. It contains the hRCC breakpoint de®ned by a balanced reciprocal translocation, t(3;8)(p14.2;q24.13) (Cohen et al., 1979) with a hereditary predisposition to develop RCC (hRCC). It also contains FRA3B, the most frequently inducible fragile site in the human genome (Smeets et al., 1986) . The biological significance of FRA3B may be its potential involvement in several malignancies. The recently identi®ed FHIT gene encompasses the FRA3B region and the hRCC breakpoint. The hRCC breakpoint and FRA3B are cytologically indistinguishable from each other (Wilke et al., 1994) , but detailed molecular analysis with a YAC clone identi®ed by Boldog et al. (1993) revealed that the hRCC breakpoint was proximal to both aphidicolin-induced breakpoints generated in a chromosome 3-only somatic cell hybrid (Wang et al., 1993) and a region of consistent breakage observed when lymphocytes were cultured in the presence of aphidicolin (Paradee et al., 1995 (Paradee et al., , 1996 .
In our analysis of this region, we were able to score more precisely breakpoints and LOH in both nonpapillary and papillary RCCs. The region most frequently lost was 3p14, with 69/94 (73%) samples showing LOH for one or more microsatellites from the 3p14.1 ± 14.2 region, which contains the FHIT gene. All the markers from 3p14.1 ± 14.2 showed LOH in 50% of RCCs. The two markers (D3S1480 and D3S1481) that most frequently showed LOH (58% and 68% respectively) are just upstream of the noncoding exon 4 of the FHIT gene, in intron 3. D3S4260 and D3S2757 lie between exon 4 and 5 of the FHIT gene (intron 4) and D3S1300 is between exon 5 and exon 6, in intron 5 (Figure 1 ). The frequencies of LOH with these three markers were less than seen with the proximal markers D3S1480 and D3S1481. This seems to indicate that in these RCC samples, the region of highest loss is upstream to the location of the coding region of the FHIT gene. Only three tumors (RC2, RC6, and RC20) showed LOH of markers that did not include any of the markers in 3p14.1 ± 14.2. None of the microsatellite markers detected homozygous deletions. This is similar to the observations of .
Sixty-nine of the RCC samples had two or more detectable 3p breakpoints (35 had four or more breakpoints). Breakpoints within FRA3B and its closely surrounding region were the most commonly observed breakpoints. Thus, FRA3B may be responsible for considerable breakage and loss of 3p sequences in RCC and possibly many other cancers. The number of breakpoints in these tumors clearly indicates that most of the tumors in this study had interstitial deletions of 3p sequenes. Only eight tumors showed complete loss of 3p distal to a single breakpoint., This is in marked contrast to the report by Wilhelm et al. (1995) . In the present study, we have used a much higher density of markers in the 3p14.2 region (®ve markers within one megabase). The saturation of any particular region of the chromosome with closely spaced markers enables one to properly assess the interstitial breaks more precisely. The markers used by Wilhelm et al were not as closely spaced (at least in 3p14.2 region) as those in this study. In addition, Wilhelm et al. reported 3p  RC1  RC2  RC3  RC4  RC5  RC6  RC7  RC8  RC9  RC10  RC11  RC12  RC13  RC14  RC16  RC17  RC19  RC20  RC22  RC23  RC25  RC26  RC27  RC28  RC29  RC30  RC31  RC33  RC35  RC36  RC37  RC38  RC39  RC40  RC41  RC42  RC43  RC44  RC45  RC46  RC47  RC48  RC49  RC50  RC51  RC52  RC53  RC54  RC55  RC56  RC57  RC58  RC59  RC60  RC61  RC62  RC63  RC64  RC65  RC66  RC67  RC68  RC70  RC71  RC72  RC73  R1  R8  R11  R12  R13  R16  R17 RC1  RC2  RC3  RC4  RC5  RC6  RC7  RC8  RC9  RC10  RC11  RC12  RC13  RC14  RC16  RC17  RC19  RC20  RC22  RC23  RC25  RC26  RC27  RC28  RC29  RC30  RC31  RC33  RC35  RC36  RC37  RC38  RC39  RC40  RC41  RC42  RC43  RC44  RC45  RC46  RC47  RC48  RC49  RC50  RC51  RC52  RC53  RC54  RC55  RC56  RC57  RC58  RC59  RC60  RC61  RC62  RC63  RC64  RC65  RC66  RC67  RC68  RC70  RC71  RC72  RC73  R1  R8  R11  R12  R13  R16  R17  R20  R23  R24   77  83  61  36  78  59  84  80  41  66  75  55  74  60  74  66  70  68  56  84  66  66  67  58  31  60   77  54  33   72  23  73  66  63  63  69  72  73  61  64  50  57  57  45  51  63  44  48  69  61  57  62  62  70  63  57  67  78  71  75  43  38   75  64  49  70  59  66  53  58  63  51 72 II   II  II  II-II  I-II   HIGH  HIGH  MODERATE   HIGH  LOW  I   III-IV   I  INTERMEDIATE   MODERATE  III  I  II  II-IV   I  II   Low to intermediate  IV   II-III  II  III   III  LOW   III  II  III  II  II  II FRA3B breakpoints in renal cell carcinoma V Shridhar et al 1994). The microsatellite analysis in this study has revealed that more than 50% (5/9) of the papillary tumors have loss of heterozygosity (Table 1) . Three of these ®ve tumors (R24, R27, and R30), had LOH of several markers, while, the other two tumors, RC1 and RC26, had LOH for a single marker in 3p14.2 and 3p14.1 respectively. This is in marked contrast to the reports published by other groups. In the original study of papillary tumors by Kovacs (1989) , no 3p rearrangements were found by karyotypic analyses. In the same year Kovacs et al (1989) , studied LOH by RFLP analysis of seven papillary and 13 nonpapillary RCCs with DNF15S2 (3p21.3), Cerb A and C raf-1 (3p25). They found no evidence of LOH with these probes in papillary tumors. Presti et al., (1993) found that two of nine papillary tumors (22%) exhibited 3p deletions and both were of basophilic cell type. Shuin et al., (1994) + phenotype in the oncocytomas they analysed. In addition, they did not observe any LOH in the tumors that had this phenotype. In this study, the samples that showed MIN also displayed LOH of some of the markers. (Table 1: samples RC35, 36, 37, 38, 46, and 63) . The reason for these dierences are unclear. There was no association between MIN in these samples and tumor grade or stage. This is similar to the observation of Thrash-Bingham et al. (1995) .
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Like other groups, we did not ®nd any association of tumor stage or grade with allele loss. The observations in this report adds to the increasing evidence of loss of heterozygosity involving 3p markers in RCC samples, and supports the probable involvement of the constitutive fragile site in the generation of breakpoints in these tumors. 
Materials and methods
Tumor samples
DNA extraction
High molecular weight DNA was isolated from tumor and normal tissue by standard phenol-chloroform methods. Tumor DNA was obtained from snap-frozen tissue, whereas paired noncancerous DNA was obtained from normal kidney (histopathologically con®rmed) obtained from each patient.
Microsatellite analysis
The 94 paired normal and tumor samples were analysed with ®ve microsatellite markers derived from the region covered by the 1330 Kb non-chimeric YAC YC850A6. These markers were: D3S1480 (which is localized just proximal to the hRCC breakpoint), D3S1481 (localized just distal to hRCC). Two new markers generated from this laboratory; D3S4260 (which de®nes the proximal border of FRA3B); and D3S2757 (which de®nes the distal border of FRA3B); and D3S1300 (localized between D3S2757 and the telomeric end of YC850A6). Also included in this analysis were two additional 3p14 microsatellites, D3S1312 and D3S1600, which are localized proximal to the hRCC breakpoint within 3p14.1 Finally, 11 additional microsatellite markers chosen to cover the remainder of 3p were: D3S1577 (3p12.1), D3S1284 (3p13), D3S1266 (3p13), D3S1606 (3p21.1), D3S1029 (22p21.3), D3S1277 (3p23), D3S1599 (3p24.2), D3S1560 (3p25.3) and D3S1270 (3p26).
Conditions for the ampli®cation of D3S1600, D3S1312, D3S1480, D3S1300, D3S1577, D3S1284, D3S1266, D3S1606, D3S1029, D3S1277, D3S1599, D3S1560 and D3S1270 were as described by Research Genetics. One primer from each microsatellite was end-labeled using T4 kinase and [ 32 P]-ATP as previously described (Shridhar et al., 1994) .
Primers for the ampli®cation of the proximal tetranucleotide (D3S4260) were: Forward: 5'-CTGCAAAGAGGAAG-GAAGGG-3'; and Reverse: 5'-TGTGAACTGTCAATC-CATCCA-3'. Primers for ampli®cation of the distal dinucleotide repeat, D3S2757, were Forward: 5'-TTTTATG-CAAAAAGAGGTCACTGCT-3'; and Reverse: 5'-CAT-CACCTGTGTTTGGTTTGGA-3'. The PCR conditions were: denaturation at 958C for 3 min and then 30 cycles of 948C denaturation for 30 s, 628C (638C for D3S2757) reannealing for 30 s, and 728C for elongation for 30 s. After 30 cycles the last elongation was at 728C for 5 min. The PCR products were denatured and then run on 6% polyacrylamide sequencing gels containing 8 M urea. The gels were then dried and autoradiographed for 16 ± 24 h and then scored for LOH. Allelic imbalance indicative of LOH were scored when there was a loss of intensity of one allele in the tumor sample with respect to the matched allele from normal tissue. The evaluation of the intensity of the signal between the dierent alleles was determined by visual examination by four independent viewers (VS, LW, RR and CM).
